Microbiota and metabolic dysfunction associated with steatotic liver disease
Disease progression in metabolic dysfunction-associated steatotic liver disease (MASLD) is driven by multiple mechanisms that act together in genetically predisposed subjects. Amongst others, the gut-liver axis plays a crucial role in the development and progression of MASLD. This inevitably involve...
Saved in:
Main Authors: | Q. Zhu, S. Francque, W. Kwanten |
---|---|
Format: | Article |
Language: | English |
Published: |
Verduci Editore
2024-09-01
|
Series: | Microbiota in Health and Disease |
Subjects: | |
Online Access: | https://www.microbiotajournal.com/wp-content/uploads/sites/7/2024/09/e1115.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A narrative review about cognitive impairment in Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD): Another matter to face through a holistic approach
by: Marica Meroni, et al.
Published: (2025-02-01) -
Dietary Interventions and Physical Activity as Crucial Factors in the Prevention and Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Paweł Rajewski, et al.
Published: (2025-01-01) -
Nicotinamide Adenine Dinucleotide Phosphate Oxidases and Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Vittoria Cammisotto, et al.
Published: (2025-01-01) -
Abnormal ac4C modification in metabolic dysfunction associated steatotic liver cells
by: Xiqian Zhang, et al.
Published: (2025-01-01) -
Ferroptosis as a potential connection between schizophrenia and metabolic dysfunction-associated steatotic liver disease – a narrative review
by: Jakub Rogalski, et al.
Published: (2024-09-01)